| pubmed-article:6146372 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C0086343 | lld:lifeskim |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C0040616 | lld:lifeskim |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:6146372 | lifeskim:mentions | umls-concept:C1521761 | lld:lifeskim |
| pubmed-article:6146372 | pubmed:dateCreated | 1984-9-4 | lld:pubmed |
| pubmed-article:6146372 | pubmed:abstractText | Factors associated with psychiatric outcome were examined in a series of 87 patients who had presented in general practice with new episodes of minor affective disorder. Two outcome measures were used: (i) Status on Present State Examination (PSE) seven months after initial consultation; (ii) prescribing of psychotropic medication between one-month and seven-month follow-up assessments. Outcome according to the PSE was significantly associated with: worse measures of psychiatric state (General Health Questionnaire, Profile of Mood states) and of social functioning (SAS-M) at initial consultation and one month later; and with persistent anxious or depressed mood during the follow-up period; but not with life events. During the follow-up period 20 patients received at least one psychotropic prescription; they were significantly associated with worse initial GHQ scores, consumption of tobacco and non-prescribed medication, and initial anxiety. A sub-group of 11 patients received multiple psychotropic prescriptions; they were significantly associated with the same initial measures, and also with poor outcome measures (psychiatric and social). | lld:pubmed |
| pubmed-article:6146372 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6146372 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146372 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6146372 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6146372 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6146372 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:6146372 | pubmed:issn | 0007-1250 | lld:pubmed |
| pubmed-article:6146372 | pubmed:author | pubmed-author:GateAA | lld:pubmed |
| pubmed-article:6146372 | pubmed:author | pubmed-author:MartinPP | lld:pubmed |
| pubmed-article:6146372 | pubmed:author | pubmed-author:BonoLL | lld:pubmed |
| pubmed-article:6146372 | pubmed:author | pubmed-author:CatalanJJ | lld:pubmed |
| pubmed-article:6146372 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6146372 | pubmed:volume | 144 | lld:pubmed |
| pubmed-article:6146372 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6146372 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6146372 | pubmed:pagination | 603-10 | lld:pubmed |
| pubmed-article:6146372 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:meshHeading | pubmed-meshheading:6146372-... | lld:pubmed |
| pubmed-article:6146372 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6146372 | pubmed:articleTitle | The effects of non-prescribing of anxiolytics in general practice. II. Factors associated with outcome. | lld:pubmed |
| pubmed-article:6146372 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6146372 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6146372 | lld:pubmed |
